The defining constraint of an early-stage biotech company is not capital or science — it is attention. Founding teams with deep technical expertise find themselves spending a disproportionate share of their week on administrative tasks that have nothing to do with moving a pipeline asset forward. A 2025 survey published in BioPharm International found that biotech founders and senior scientists at pre-clinical and Phase I companies spend an average of 28% of their working week on administrative work they describe as "non-value-adding but necessary."
Virtual assistants are becoming a standard part of the lean biotech operating model, handling the administrative layer that keeps the organization compliant, funded, and communicating — while scientists stay in the lab.
Research Administration Without a Full-Time Administrator
Early biotech companies rarely have a dedicated research administrator. That function falls to the CSO, a senior scientist, or a co-founder who is also managing scientific strategy, vendor relationships, and hiring. The result is a backlog of administrative tasks that creates risk across multiple fronts.
Virtual assistants trained in research administration can manage vendor purchase order processing and tracking, equipment maintenance scheduling, lab supply inventory monitoring, grant milestone documentation, and meeting coordination for scientific advisory boards. These tasks require organizational discipline and attention to detail — skills VAs are trained for — rather than scientific expertise.
For companies running under NIH, BARDA, or SBIR/STTR grant frameworks, VA support for milestone documentation and progress report preparation can be particularly valuable. Mismanagement of grant reporting obligations is a common cause of funding interruption at early-stage companies.
Investor Communications and Board Reporting
Fundraising is a continuous activity at pre-revenue biotech companies. Managing investor relationships between funding rounds requires regular communication: monthly or quarterly updates, data room maintenance, due diligence request responses, and meeting scheduling. This work is important but highly delegable.
Virtual assistants can draft investor update emails for founder review, maintain and organize data room document sets, coordinate due diligence document requests from prospective investors, manage calendars for investor calls and site visits, and track follow-up commitments made during investor meetings. This ensures that investor relationships are maintained consistently without requiring the CEO or CSO to manage every logistical detail.
Board reporting is a related function. VAs can prepare board meeting packages by compiling pipeline updates, financial summaries, and milestone trackers into presentation-ready formats for founder review and sign-off. This reduces the two to three days of prep time that founders typically spend before board meetings.
Regulatory Compliance Calendar and Filing Support
Biotech startups operating under FDA oversight — whether managing IND applications, interacting with the IADP, or working toward BLA filing milestones — carry a significant regulatory calendar burden. Missing a reporting deadline or failing to maintain a current regulatory correspondence file can have serious consequences.
Virtual assistants can maintain a regulatory milestone calendar, send advance reminders for filing deadlines, organize regulatory correspondence chronologically, track commitments made in FDA meeting minutes, and prepare cover letter drafts for routine submissions. While regulatory strategy and submission content require qualified regulatory affairs professionals, the organizational and logistical layer is well-suited to VA support.
For companies also managing ISO compliance or laboratory accreditation requirements, VAs can track internal audit schedules, document corrective actions, and prepare materials for external auditor visits.
The Talent Economics of Biotech VA Hiring
A junior research administrator or executive assistant in a biotech hub market — Boston, San Diego, or the Research Triangle — commands a salary of $55,000 to $75,000 annually, plus benefits and equity. For a company managing runway carefully, that is a significant recurring commitment.
A professional VA providing 20 to 40 hours per week of specialized administrative support typically costs $10,000 to $22,000 annually through a staffing partner — a cost that can be scaled up or down with funding cycles. Several Series A biotech companies have reported using VA support as a bridge between rounds, replacing a full-time administrative hire until headcount budget is available.
For biotech startups that need to protect scientific productivity while keeping the operational layer running, Stealth Agents provides virtual assistants trained to support life sciences administrative workflows including investor relations, grant administration, and compliance tracking.
Sources
- BioPharm International, Founder Time Allocation in Early-Stage Biotech, 2025
- NIH, SBIR/STTR Progress Report Requirements, 2024
- BARDA, Grant Milestone Reporting Guidance, 2024
- BioWorld, Biotech Operating Model Benchmarks for Lean Teams, 2025